Novartis
NVS
NVS
986 hedge funds and large institutions have $19.3B invested in Novartis in 2018 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 343 increasing their positions, 397 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less repeat investments, than reductions
Existing positions increased: 343 | Existing positions reduced: 397
21% less first-time investments, than exits
New positions opened: 65 | Existing positions closed: 82
46% less funds holding in top 10
Funds holding in top 10: 24 → 13 (-11)
Holders
986
Holding in Top 10
13
Calls
$96.7M
Puts
$26.8M
Top Buyers
| 1 | +$298M | |
| 2 | +$218M | |
| 3 | +$137M | |
| 4 |
D.E. Shaw & Co
New York
|
+$77.5M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$75.1M |
Top Sellers
| 1 | -$365M | |
| 2 | -$65.8M | |
| 3 | -$64.3M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$44.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$37.5M |